v3.26.1
Assets and Liabilities Held For Sale and Discontinued Operations
6 Months Ended
Jun. 30, 2026
Assets and Liabilities Held For Sale and Discontinued Operations [Abstract]  
Assets and liabilities held for sale and discontinued operations
4.Assets and liabilities held for sale and Discontinued operations

 

Pursuant to an Asset Purchase Agreement with an unrelated third party, dated December 31, 2024, the Company agreed to sell its skincare business for (i) 1,267,040 shares of common stock of the buyer, having a market value of $728,550 at the closing of the agreement; (ii) buyer’s assumption of certain liabilities; and, (iii) $56,525 in cash, to be paid upon the sale of specified inventory existing as of the Closing.

Following the closing which occurred on January 16, 2025 (the “Closing” or “Closing Date”), buyer will pay additional earn-out consideration for the sale, if and when payable: (a) buyer will pay, for each year ending on the anniversary of the Closing Date during the five-year period following the Closing, an amount, if any, equal to 5% of the sales generated during such year from the existing products as of the Closing; and (b) buyer will pay a one-time payment of $500,000 if buyer achieves $500,000 in revenue from sales of the existing hair and scalp products as of the Closing on or before the 24-month anniversary of the Closing Date.

 

The following table summarizes the major line items for the skincare business that are included in loss from discontinued operations, net of taxes in the consolidated statements of operations:

 

   Three months ended
June 30,
2026
   Three months ended
June 30,
2025
   Six months ended
June 30,
2026
   Six months ended
June 30,
2025
 
Revenue  $
-
   $
-
   $
-
   $152,381 
Cost of goods sold   
-
    
-
    
-
    30,530 
Gross profit  $
-
   $
-
   $
-
   $121,851 
                     
Expenses                    
Depreciation   
-
    
-
    
-
    517 
Marketing and promotion   
-
    
-
    
-
    6,924 
Consulting fees   
-
    
-
    
-
    
-
 
Office and administrative   
-
    7,661    
-
    54,875 
Professional fees   
-
    
-
    
-
    50,460 
Investor relations   
-
    
-
    
-
      
Research and development   
-
    
-
    
-
    16,921 
Foreign exchange (gain) loss   
-
    
-
    
-
    1,875 
Travel and entertainment   
-
    
-
    
-
    10,726 
Total expenses  $
-
   $7,661   $
-
   $142,298 
                     
Other income (expense)                    
Other income   17,590    24,796    37,091    49,614 
Interest expense   
-
    
-
    
-
    
-
 
Loss on the sale of Skincare   
-
    
-
    
-
    (39,676)
Net income (loss) from discontinued operations  $17,590   $17,135   $37,091   $(10,509)

 

The Company recorded a loss on sale of discontinued operations of $39,676. The proceeds on sale, which was the fair value of the buyer shares received on Closing, amounted to $728,550, and the carrying amounts of the net assets and liabilities sold amounted to $768,226.

 

The following represents the cash flows from operating and investing activities of discontinued operations for the six months ended June 30, 2026 and 2025:

 

   June 30,
2026
   June 30,
2025
 
Cashflows used in operating activities  $
-
   $(174,767)
Cashflows used in investing activities   
-
    
-